All articles by Srivani Venna

1. Atreca doses first patient in Phase Ib trial of oncology drug

   Biotechnology company Atreca has dosed the first patient in a Phase Ib clinical trial evaluating monoclonal antibody ATRC-101 for the…
   Read More…

   14 Feb
2. WPD and CNS partner for paediatric brain cancer trial

   WPD Pharmaceuticals and CNS Pharmaceuticals are set to initiate a Phase I clinical trial for Berubicin, an anthracycline, in paediatric…
   Read More…

   13 Feb
3. Longeveron completes patient enrolment in Aging Frailty trial

   Longeveron has completed patient enrolment in its Phase IIb Aging Frailty trial designed to evaluate the safety and efficacy of…
   Read More…

   13 Feb
4. Genome & Company, Merck and Pfizer sign clinical trial agreement

   Genome & Company, Merck and Pfizer have signed a clinical trial collaboration and supply agreement to evaluate GEN-001 therapy in…
   Read More…

   14 Jan
5. Akero to expand ongoing Phase IIa trial of AKR-001 for NASH

   Akero Therapeutics is set to expand the ongoing Phase IIa BALANCED study of Fc-FGF21 fusion protein AKR-001 to include an…
   Read More…

   14 Jan
6. Compass Pathways reports positive data from psilocybin trial

   Mental healthcare company Compass Pathways has reported positive results from a Phase I trial evaluating the safety of COMP360 (psilocybin)…
   Read More…

   13 Dec
7. Lilly launches trial to examine selpercatinib in NSCLC patients

   Eli Lilly and Company has launched the LIBRETTO-431 Phase III clinical trial (NCT04194944) to examine selpercatinib (LOXO-292) for treatment-naïve RET…
   Read More…

   12 Dec
8. AstraZeneca and Daiichi Sankyo report positive cancer drug trial data

   AstraZeneca and Daiichi Sankyo have reported that experimental breast cancer drug trastuzumab deruxtecan (DS-8201) halted cancer in women who had…
   Read More…

   12 Dec
9. ProQR doses first patient in Aurora trial of retinal disease therapy

   ProQR Therapeutics has dosed the first patient in a Phase I/II Aurora clinical trial to evaluate QR-1123 in patients with…
   Read More…

   12 Dec
10. Sanofi’s trial of sutimlimab meets primary and secondary endpoints

    Sanofi has reported positive results from a pivotal Phase III trial of sutimlimab for the treatment of people with cold…
    Read More…

    11 Dec